Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dibazole eye drops vs low-dose atropine for myopia control in children
ChiCTR2500106942Phase 2Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bendazol in myopia (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Spherical equivalent refraction (SER) change at 1 year. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bendazol
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2500106942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106942.